Dr. Bertalan Mesko discusses the role of artificial intelligence in the future of health care, how patients are driving adoption – and the seemingly t...

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an ex...

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, acco...

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.

CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.

Catalent says making its technology available to industry will not affect its competitive edge.

Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field...